B O O K - American College of Rheumatology

Abelson, Abby Goulder, MD
Education
Disclosure:Nothing to Disclose
Abraham, David, MD
Systemic Sclerosis, Fibrosing Syndromes, and
Raynaud’s - Pathogenesis, Animal Models and
Genetics
Disclosure:Nothing to Disclose
Adams, Barbara S, MD
Pediatric Rheumatology - Pathogenesis
and Genetics: Biological Basis for Pediatric
Rheumatic Disease
Disclosure:
Aringer, Martin
Rheumatoid Arthritis Treatment - Small
Molecules, Biologics and Gene Therapy: Safety
and Efficacy I
Disclosure: Centocor, 2; Roche, 5
Asahara, Hiroshi, MD, PhD
Biology and Pathology of Bone and Joint:
Molecular Basis of Osteoarthritis
Disclosure:Nothing to Disclose
Backman, Catherine L, PhD, OT(C)
Keep Working with Arthritis
Disclosure: Nothing to Disclose
A
B
Baer, Alan N, MD
Sjögren’s Syndrome
Disclosure:Nothing to Disclose
Baron, Murray
Systemic Sclerosis, Fibrosing Syndromes, and
Raynaud’s - Clinical Aspects and Therapeutics II
Disclosure: Nothing to Disclose
Birnbaum, Neal S, MD
Rheumatoid Arthritis - Clinical Aspects:
Preclinical RA and Early RA I
Disclosure: AMgen/Pfizer, Amgen, Centocor,
UCB, Genentech, 8
Block, Joel A, MD
Osteoarthritis - Clinical Aspects: Pain and
Biomechanics
Disclosure: KAI / NIH, 9; NiCOx, 5; OA and
Cartilage, 9; Pleiad, 5
Brandenstein, Jane S, MD
Physical and Psychosocial Challenges in
Scleroderma
Braun, Juergen, MD
Spondylarthropathies and Psoriatic Arthritis -
Clinical Aspects and Treatment: Imaging I
Breban, Maxime A
Spondylarthritis and Psoriatic Arthritis:
Pathogenesis, Etiology, and Animal Models
Disclosure: Nothing to Disclose
Brunner, Hermine, MD
ACR/ARHP Combined Pediatric Rheumatology:
Clinical and Therapeutic Aspects: Quality of Life
in Children and Adolescents with Arthritis
Buch, Maya H, MD, PhD
Rheumatoid Arthritis Treatment - Small
Molecules, Biologics and Gene Therapy: Safety
and Efficacy I
Disclosure: Abbott, 5; Pfizer/Wyeth, 5; Roche, 5
Bunyard, Matthew P, MD
Quality Measures and Innovation in Practice
Management and Care Delivery
Disclosure: Nothing to Disclose
C
Carette, Simon, MD
ANCA-associated Vasculitis I
Disclosure:Nothing to Disclose
Carlone, Joyce P, MD
Rheumatoid Arthritis: From Clinic to Home
Disclosure:Nothing to Disclose
Chakravarty, Eliza F, MD
Systemic Lupus Erythematosus - Clinical Aspects
and Treatment: Renal
Disclosure:Nothing to Disclose
Chatham, W. Wimm, MD
Miscellaneous Rheumatic and Inflammatory
Diseases
Disclosure: Nothing to Disclose
Chen, Pojen P, MD
Antiphospholipid Syndrome I
Disclosure:Nothing to Disclose
Choy, Ernest, MD
Rheumatoid Arthritis - Clinical Aspects:
Radiographic and Other Outcomes in RA IV
Disclosure: Abbott Immunology Laboratories,
5; Astra Zeneca, 5; Chelsea Therapeutics, 2;
Chugai Pharma, 5; Chugai Pharma, 8; Eli Lilly, 5;
Eli Lilly, 8; GSK, 5; Jazz Pharmaceuticals, 2; Jazz
Pharmaceuticals, 5; MSD, 2; Pfizer, 5; Roche, 2;
Roche, 5; Roche, 8; Synovate, 5; UCB, 2l UCB, 5;
UCB, 8; Wyeth, 5
Cibere, Jolanda
Epidemiology and Health Services Research:
General Interest
Disclosure: Amgen Inc, 2l Centocor Research and
Development Inc, 2
Clancy, Robert M, MD
Innate Immunity and Rheumatic Disease
Disclosure:Nothing to Disclose
Clauw, Daniel J, MD
Fibromyalgia and Soft Tissue Disorders
Disclosure:Nothing to Disclose
Clegg, Daniel O, MD
Spondylarthropathies and Psoriatic Arthritis -
Clinical Aspects and Treatment: Biomarkers II
Disclosure:Nothing to Disclose
Cohen, Philip L, MD
Systemic Lupus Erythematosus - Animal Models
Disclosure: Nothing to Disclose
Cooper, Robert G, MD
Muscle Biology, Myositis and Myopathies:
Insights into the Pathogenesis and Outcomes of
Myositis
Disclosure:Nothing to Disclose
Cohen, Philip L, MD
Systemic Lupus Erythematosus - Animal Models
Disclosure: Nothing to Disclose
Cope, Andrew P
Rheumatoid Arthritis - Human Etiology and
Pathogenesis: Anti-CCP in RA Etiology and
Pathogenesis II
Disclosure: Nothing to Disclose
Cornell, Patricia J, BSc
Issues in Lupus
Disclosure:Nothing to Disclose
Criswell, Lindsey A
Genetics, Genomics and Proteomics: RA and
Other Rheumatic Diseases
Disclosure: Nothing to Disclose
Cronstein, Bruce N
Cell-Cell Adhesion, Cell Trafficking and
Angiogenesis
Disclosure: Can-Fite Biopharmaceuticals, 1;
Endocyte, 5; King Pharmaceuticals, 7; NIH, 2;
NYU SoM, 9; OSI Pharmaceuticals, 2; Regeneron,
5 URL, 5
Curtis, Jeffrey R, MD, MPH
Epidemiology and Health Services Research:
Gout
Disclosure:Nothing to Disclose
D
DallEra, Maria
Systemic Lupus Erythematosus - Clinical Aspects
and Treatment: New Therapies
Disclosure: Nothing to Disclose
De Pablo, Paola, MD
Systemic Lupus Erythematosus - Clinical Aspects
and Treatment: SLE and Cardiovascular Disease
Disclosure: Nothing to Disclose
Dellaripa, Paul F, MD
Rheumatoid Arthritis - Clinical Aspects: RA and
Cardiovascular Disease III
Disclosure:Nothing to Disclose
Distler, Oliver
Cytokines, Mediators, Gene Regulation I
Disclosure: Actelion, Pfizer, Encysive and
ERgonex, 9; Actelion, Pfizer, Encysive, FibroGen,
Ergonex, NicOx, BMS, Biovitrium, 2; Biovitrium, 5
Dougados, Maxime, MD
Spondylarthropathies and Psoriatic Arthritis -
Clinical Aspects and Treatment: Therapy III
Disclosure: Abbott, 2, 5; Pfizer, 2, 5; Roche, 2, 5;
Sanofi, 2, 5
Espinoza, Luis R, MD
Spondylarthropathies and Psoriatic Arthritis -
Clinical Aspects and Treatment: Therapy III
Disclosure:Nothing to Disclose
Finnegan, Alison, PhD
Cytokines, Mediators, Gene Regulation I
Disclosure:Nothing to Disclose
F
ABSTRACT MODERATOR DISCLOSURE
2010 Program Book 375